US FDA Wants Generic Sponsors To Know If Anything Missing Before Submitting ANDA
Proposed assessment system upgrade would add automation to potentially reduce refuse-to-file actions and review cycles.
You may also be interested in...
ANDA sponsors fret price erosion – and potential changes to 180-day exclusivity.
President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.
Concept mentioned during Gottlieb’s 'star' turn at Davos may sound similar to now-withdrawn generic labeling rule, but actually appears based on a proposal from the Friends of Cancer Research to get current clinical guidelines reflected on labels.